DSC ADVISORS L P
Q4 2023 Form 13-F

CHICAGO, ILLINOIS
CIK 0001299434 · CRD 158312 · SEC-registered investment adviser
Consolidated report · includes 1 manager since Q2 2017
$60.5M Reported Value Total
SEC Registered Discretionary Manager
Private funds (Form ADV)
6 funds · $483.9M gross asset value
Hedge Fund: $483.9M
Source: Form ADV filed 2020-02-14
Reported value
$60.5M
Quarter over quarter
+1.9%
Holdings
26
Top-10 concentration
90.9%

Filing Structure

Reports holdings for

  • DSCQG PR LLC (not a 13F filer in our records) · Q4 2016 – Q1 2017 · declared by one filing
  • DACQG PR LLC (not a 13F filer in our records) · Q3 2016 – Q3 2016 · declared by one filing
  • DSC Quantitative Group, LLC (not a 13F filer in our records) · Q2 2013 – Q2 2016 · declared by one filing

Key People

Form ADV owners & control persons
Andrew Gordon Bluhm
PRINCIPAL
Amy Catherine Close
CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2023 13F record

Q4 2023 13F filing summary

Q4 2023 Form 13F portfolio summary
Period of report December 31, 2023
Filed February 14, 2024
Form 13F-HR
Reported value $60.5M
Positions 26
Change in reported value -22.3%
New positions 6
Exited positions 6
Position turnover 37.5%
Top-10 concentration 90.9%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2024 13F
Filed Nov 14, 2024
19 $11.0M
Q2 2024 13F
Filed Aug 14, 2024
23 $30.0M
Q1 2024 13F
Filed May 15, 2024
30 $62.6M
Q4 2023 13F
Filed Feb 14, 2024
26 $60.5M
Q3 2023 13F
Filed Nov 14, 2023
26 $77.9M
Q2 2023 13F
Filed Aug 14, 2023
25 $66.7M
Q1 2023 13F
Filed May 15, 2023
19 $114.5M
Q4 2022 13F
Filed Feb 14, 2023
15 $43.5M
Q3 2022 13F
Filed Nov 14, 2022
93 $97.0M
Q2 2022 13F
Filed Aug 15, 2022
109 $100.1M
Q1 2022 13F
Filed May 16, 2022
127 $290.3M
Q4 2021 13F
Filed Feb 14, 2022
68 $129.4M
Q3 2021 13F
Filed Nov 15, 2021
68 $98.5M
Q2 2021 13F
Filed Aug 16, 2021
65 $138.4M
Q1 2021 13F
Filed May 14, 2021
75 $161.4M
Q4 2020 13F
Filed Feb 16, 2021
40 $120.9M
Q3 2020 13F
Filed Nov 16, 2020
39 $149.5M
Q2 2020 13F
Filed Aug 14, 2020
29 $91.2M
Q1 2020 13F
Filed May 15, 2020
28 $102.4M
Q4 2019 13F
Filed Feb 14, 2020
79 $208.7M

26 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2023

Largest Q4 2023 13F positions by reported value
# Holding Reported value % of portfolio
1 CVS CVS HEALTH CORP $12.0M 19.86%
2 RCM R1 RCM INC $10.0M 16.59%
3 BMRN BIOMARIN PHARMACEUTICAL INC $9.6M 15.93%
4 ZBH ZIMMER BIOMET HOLDINGS INC $8.5M 14.08%
5 ABT ABBOTT LABS $8.0M 13.25%
6 EHTH EHEALTH INC $3.6M 5.91%
7 VYNE VYNE THERAPEUTICS INC $1.6M 2.68%
8 EHAB C ENHABIT INC $549.6K 0.91%
9 ADT C ADT INC DEL $511.5K 0.85%
10 UNG C UNITED STS NAT GAS FD LP $507.0K 0.84%
11 GOOGL ALPHABET INC $440.2K 0.73%
12 META META PLATFORMS INC $433.2K 0.72%
13 MSFT MICROSOFT CORP $414.4K 0.68%
14 EHAB ENHABIT INC $414.0K 0.68%
15 V VISA INC $356.4K 0.59%
16 MA MASTERCARD INCORPORATED $349.7K 0.58%
17 CRM SALESFORCE INC $336.3K 0.56%
18 ACN ACCENTURE PLC IRELAND $323.5K 0.53%
19 ADBE ADOBE INC $317.4K 0.52%
20 NFLX NETFLIX INC $284.8K 0.47%

Values as reported on the Q4 2023 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings